1. Home
  2. AMSC vs PCRX Comparison

AMSC vs PCRX Comparison

Compare AMSC & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMSC
  • PCRX
  • Stock Information
  • Founded
  • AMSC 1987
  • PCRX 2006
  • Country
  • AMSC United States
  • PCRX United States
  • Employees
  • AMSC N/A
  • PCRX N/A
  • Industry
  • AMSC Metal Fabrications
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMSC Consumer Discretionary
  • PCRX Health Care
  • Exchange
  • AMSC Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • AMSC 1.1B
  • PCRX 1.2B
  • IPO Year
  • AMSC 1991
  • PCRX 2011
  • Fundamental
  • Price
  • AMSC $30.40
  • PCRX $24.10
  • Analyst Decision
  • AMSC Strong Buy
  • PCRX Buy
  • Analyst Count
  • AMSC 3
  • PCRX 9
  • Target Price
  • AMSC $33.67
  • PCRX $29.89
  • AVG Volume (30 Days)
  • AMSC 1.5M
  • PCRX 546.7K
  • Earning Date
  • AMSC 08-05-2025
  • PCRX 07-29-2025
  • Dividend Yield
  • AMSC N/A
  • PCRX N/A
  • EPS Growth
  • AMSC N/A
  • PCRX N/A
  • EPS
  • AMSC 0.16
  • PCRX N/A
  • Revenue
  • AMSC $222,818,000.00
  • PCRX $702,772,000.00
  • Revenue This Year
  • AMSC $20.26
  • PCRX $7.54
  • Revenue Next Year
  • AMSC $12.73
  • PCRX $10.78
  • P/E Ratio
  • AMSC $189.25
  • PCRX N/A
  • Revenue Growth
  • AMSC 52.99
  • PCRX 3.08
  • 52 Week Low
  • AMSC $13.98
  • PCRX $11.16
  • 52 Week High
  • AMSC $38.02
  • PCRX $29.61
  • Technical
  • Relative Strength Index (RSI)
  • AMSC 60.50
  • PCRX 36.99
  • Support Level
  • AMSC $29.07
  • PCRX $23.99
  • Resistance Level
  • AMSC $31.12
  • PCRX $24.90
  • Average True Range (ATR)
  • AMSC 1.69
  • PCRX 0.88
  • MACD
  • AMSC -0.35
  • PCRX -0.21
  • Stochastic Oscillator
  • AMSC 37.30
  • PCRX 11.61

About AMSC American Superconductor Corporation

American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: